• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Researchers tout AI-based diabetes onset prediction method

December 2, 2022 By Sean Whooley

Klick Applied Sciences diabetes researchScientists at Klick Applied Sciences say they discovered a way to use a continuous glucose monitor (CGM) as a diabetes screening tool.

The scientists determined that they can use artificial intelligence (AI) to screen and prevent the chronic health condition. They used machine learning and 12 hours of data from CGMs to determine whether a patient had prediabetes or diabetes.

“We have demonstrated that 12 hours of monitoring can make a big difference in the lives of people at risk of developing diabetes while there’s still time to course correct,” said Jouhyun Jeon, lead scientist of the study and principal investigator at Klick Applied Sciences. “We think CGMs could be used to not just monitor diabetes – but to prevent it altogether.”

About the diabetes study

The study evaluated 600 patients. They identified as healthy, prediabetic or living with type 2 diabetes and wore a CGM for an average of 12 days. Scientists looked at glucose measurements over time and developed machine learning models. The models determined if those values could indicate whether a person was healthy, prediabetic or diabetic.

Jeon noted that the 12-hour model showed similarly high accuracy compared to results from longer intervals. It correctly identified two-thirds of patients with prediabetes. The method also showed high accuracy in identifying healthy patients and those with type 2.

According to Klick, most research draws from 10 to 14 days of readings. It also often requires analysis from expert clinicians.

“An overwhelming majority of people with early-onset diabetes are not aware of their condition and don’t consult a physician until their ability to control their blood sugar levels is irreparably damaged,” said Michael Lieberman, managing director of R&D at Klick Applied Sciences. “Our research has tremendous potential to help move blood glucose digital biomarkers into a position where they can be an invaluable tool for physicians for preventing diabetes before it starts.”

Filed Under: Diabetes, Diagnostics, Drug-Device Combinations, Featured, Patient Monitoring, Research & Development, Technology Tagged With: Klick Applied Sciences

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS